跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,521 条关于
“DXd”
全部
1,521
临床试验
981
药物
201
机构
12
资讯
327
去年
Trastuzumab Deruxtecan Shows Promise in HER2-Overexpressing NSCLC
去年
Trastuzumab Deruxtecan's Expanding Role in HER2-Expressing Solid Tumors
去年
FDA Approves Daiichi Sankyo's Dato-DXd for Breast Cancer, Expanding Treatment Options
去年
Dato-DXd Shows Promise in Previously Treated Advanced Non-Small Cell Lung Cancer
去年
T-DXd Shows Promise in HER2-Ultra Low Breast Cancer, Expanding Treatment Horizons
2年前
Trastuzumab Deruxtecan Preserves Quality of Life and Delays Pain in HR+/HER2-Low/Ultralow Metastatic Breast Cancer
去年
Trastuzumab Deruxtecan Improves PFS in HER2-Low/Ultralow Metastatic Breast Cancer Regardless of Endocrine Resistance
去年
Oncology Nurses Key to Managing T-DXd Side Effects, Including Interstitial Lung Disease
去年
Datopotamab Deruxtecan Evaluated in Phase 3 NSCLC Trials
2年前
Datopotamab Deruxtecan Shows Promise in Advanced Gynecologic Cancers
第 1 页,共 33 页
上一页
下一页